APA

Rescigno P., Lorente D., Dolling D., Ferraldeschi R., Rodrigues D. N., Riisnaes R., Miranda S., Bianchini D., Zafeiriou Z., Sideris S., Ferreira A., Figueiredo I., Sumanasuriya S., Mateo J., Perez-Lopez R., Sharp A., Tunariu N. & de Bono J. S. (2018). Docetaxel Treatment in PTEN- and ERG-aberrant Metastatic Prostate Cancers. : European urology oncology.

Chicago

Rescigno Pasquale, Lorente David, Dolling David, Ferraldeschi Roberta, Rodrigues Daniel Nava, Riisnaes Ruth, Miranda Susana, Bianchini Diletta, Zafeiriou Zafeiris, Sideris Spyridon, Ferreira Ana, Figueiredo Ines, Sumanasuriya Semini, Mateo Joaquin, Perez-Lopez Raquel, Sharp Adam, Tunariu Nina and de Bono Johann S. 2018. Docetaxel Treatment in PTEN- and ERG-aberrant Metastatic Prostate Cancers. : European urology oncology.

Harvard

Rescigno P., Lorente D., Dolling D., Ferraldeschi R., Rodrigues D. N., Riisnaes R., Miranda S., Bianchini D., Zafeiriou Z., Sideris S., Ferreira A., Figueiredo I., Sumanasuriya S., Mateo J., Perez-Lopez R., Sharp A., Tunariu N. and de Bono J. S. (2018). Docetaxel Treatment in PTEN- and ERG-aberrant Metastatic Prostate Cancers. : European urology oncology.

MLA

Rescigno Pasquale, Lorente David, Dolling David, Ferraldeschi Roberta, Rodrigues Daniel Nava, Riisnaes Ruth, Miranda Susana, Bianchini Diletta, Zafeiriou Zafeiris, Sideris Spyridon, Ferreira Ana, Figueiredo Ines, Sumanasuriya Semini, Mateo Joaquin, Perez-Lopez Raquel, Sharp Adam, Tunariu Nina and de Bono Johann S. Docetaxel Treatment in PTEN- and ERG-aberrant Metastatic Prostate Cancers. : European urology oncology. 2018.